GSI-953

DRUG3 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

Alzheimer DiseaseHealthy

Phase 1

Study Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953

CompletedNCT00441987

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2007-02-28End: 2009-07-31Updated: 2022-05-03

Study Evaluating GSI-953 in Healthy Young and Alzheimer's Patients

CompletedNCT00479219

Wyeth is now a wholly owned subsidiary of PfizerAlzheimer Disease

Start: 2007-05-31End: 2007-10-31Updated: 2008-07-10

Study Evaluating Multiple Doses Of GSI-953 Within The Elderly Population

CompletedNCT00547560

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2007-08-31End: 2009-10-31Updated: 2011-04-04